Genentech, OSI Pay $67M To Settle Cancer Drug False Claims Lawsuit
SAN FRANCISCO — Genentech Inc. and OSI Pharmaceuticals LLC on June 6 agreed to pay $67 million to resolve a False Claims Act lawsuit alleging that they misrepresented the effectiveness of...To view the full article, register now.
Already a subscriber? Click here to view full article